Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Comment by helpline88on Sep 13, 2024 4:20pm
194 Views
Post# 36223058

RE:RE:RE:RE:RE:Suspension

RE:RE:RE:RE:RE:SuspensionThank you for your comments CancerSlayer. I can't say that I have read unequivocally that the patents reached true protection. But why would the company not complete the true patent protection for it's Psilocybin technology? All along this technology was the company's main focus. What would be the reason for the Company not to fully protect it's technology? Maybe this makes it easier for Right Season Investments to come in and scoop it. I am also thinking Right Seasons knows what they are doing but I could be wrong. Again this only quess. There is not much to go on. I wish the company would send out a news release clarifying what is going on with the company.  
 
Recently the US Federal government voted against legalizing Psilocybin. This had to be a big set back for Core. Now I am quite sure some time in the not to distant future Psilocybin will be legal at least for some medical use which would be huge for Core. Psilolcybin has been proven to help people with mental illness and mental illness is a huge problem. It will just take time like how it took time for marijunana. The Psilocybin sector is just to early. But I am thinking Core Technology if it is everything they say it is could be eventually be quite valuable.  
<< Previous
Bullboard Posts
Next >>